Short-Term and Long-Term Cognitive Outcomes in Adults After Cardiac Surgery
NCT ID: NCT05172362
Last Updated: 2021-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
250 participants
OBSERVATIONAL
2011-02-02
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In summary, the long-term neurophysiological effects following cardiac surgery are poorly understood. Moreover, little is known about the structure of cognitive impairment during the long-term postoperative period and the corresponding functional activity of the brain. The detection of minimal or subclinical signs of brain dysfunction following CABG is still under debate. Prior studies have shown the relationship between EEG abnormalities and cognitive impairment. However, little is known about EEG changes and concentrations of markers of the neurovascular unit in patients after on-pump CABG. To facilitate and improve the diagnostic accuracy, detailed neuropsychological examination using the multichannel digital EEG, serum concentrations of markers of the neurovascular unit and psychometric tests may be used to detect the long-term brain changes associated with postoperative cognitive impairment. Therefore, the study aims to evaluate the neurophysiological outcomes of patients 5-7 years after CABG.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Written informed consent
Exclusion Criteria
2. Dementia (MMSE score less than 24; FAB score less than 11; MoCA score less than 20)
3. Life-threatening rhythm disturbances
4. Chronic heart failure (NYHA functional class III and higher)
5. Chronic obstructive pulmonary disease
6. Malignant pathology
7. Drug addiction
8. Stroke
9. Brain injuries
45 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novosibirsk State University
OTHER
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olga Trubnikova
Head of Neurovascular Pathology Lab
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olga L Barbarash, MD, PhD
Role: STUDY_DIRECTOR
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal State Budgetary Scientific Institution of Research Institute of Complex Issues of Cardiovascular Diseases
Kemerovo, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Olga L Barbarash, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01/2011-2520
Identifier Type: -
Identifier Source: org_study_id